Tweet Archive for hashtag “#melanoma” « page 26
RT @DrAnjaliMahto: Annual mole checks may detect skin cancer at an earlier stage #skin #dermatology #skincancer #melanoma https://t.co/dXG0…
RT @EsteeWilliamsMD: 7 MYTHS ABOUT #MELANOMA: runnerslift.com/7-myths-about-… #skincancer #cancer @skincancerorg
RT @BrJDermatol: Image Gallery: Brain? no, melanoma goo.gl/zjQ6k7 #BJD #melanoma pic.twitter.com/7TI5O8tT45
#ASCO16 news about #melanoma #skincancer
Online now: CheckMate064-nivolumab then ipilimumab more beneficial, more tox vs reverse order in #melanoma https://t.co/dpiSm9c5uq #ASCO16
— The Lancet Oncology (@TheLancetOncol) June 4, 2016
#ASCO16 news about #melanoma #skincancer
#keytruda shows some early benefit in some but not all sarcoma patients –Dr D'Angelo #asco16 pic.twitter.com/dtbGrmzhJj
— Eric D Whitman, MD (@Melanoma_doctor) June 5, 2016
#ASCO16 news about #melanoma #skincancer
#ASCO16 Join Arie Crown Th. 2.15PM Pr Robert @GustaveRoussy KEYNOTE-001 Results: 3-y overall survival for pts w/pembro in advanced #melanoma
— GustaveRoussy (@GustaveRoussy) June 6, 2016
#ASCO16 news about #melanoma #skincancer
Predictive biomarkers for #checkpoint inhibitors, #immunotherapy, in #melanoma and #crc. https://t.co/Ewhdr0cFvU #ASCO16 @VUMChealth
— AJMC-Oncology (@EBOncology) June 6, 2016
RT @practiceupdate: .@ASCO : Pembrolizumab Improves Survival in #Melanoma ow.ly/qtXE300v2I0 #ASCO16 #skcsm
RT @MDAMelanomaOnc: Sat #ASCO16 poster 9548,M Rohlfs: BRAF +/ -MEK inhibition plus PD-1 checkpoint blockade for treatment of metastatic #me…
RT @MedscapeDerm: #ASCO16: findings from NEMO, other #Melanoma highlights. wb.md/1TYyVZH